维普中文期刊产品整合服务
12篇 您的检索式:作者名="GIESSMANN A"
    题名 作者 年代 出处 被引量
1Oral bioavailability of digoxin is enhanced by talinolol:evidence for involvement of intestinal P-glycoprotein显示文摘 Weinbvenner A Giessmann T 2000Clin Pharmacol Ther2000,6,1:1
2The talinolol double-peak phenomenon is likely caused by presystemic processing after uptake from gut lumen显示文摘Weitschies W Bernsdorf A Giessmann T 2005Pharm Res2005,22,5:1
3The talinolol double-peak phenomenon is likely caused by presystemic processing after uptake from gut lumen显示文摘Weitschies W Bernsdorf A Giessmann T 2005Pharm Res2005,22,5:1
4Multipurpose Production Line for the Coated Textile Industry显示文摘A Giessmann 1998Journal of Coated Fabrics1998,28,1:1
5The talinolol double-peak phenomenon is likely caused by presystemic processing after uptake from gutlumen显示文摘Weitschies W Bernsdorf A Giessmann T 2005Pharm Res2005,22,5:1
6The talinolol double-peak phenomenon is likely caused by presystemic processing after uptake from gut lumen显示文摘 Bernsdorf A Giessmann T 2005Pharm Res2005,22,5:1
7Oral bioavailability of digoxin is enhanced by talinolol: evidence for involvement of intestinal P-glycoprotein显示文摘Westphal K Weinbrenner A Giessmann T 2000Clin Pharrnacol Ther2000,68,:1
8Muhipurpose production line for the coated textile industry 显示文摘GIESSMANN A 1998Journal of Coated Fabrics1998,28,1:1
9Simvastatin does not influence the intestinal P-glycoprotein and MPR2, and the disposition of talinolol after chronic medication in healthy subjects genotyped for the ABCB1, ABCC2 and SLCO1B1 polymorphisms显示文摘Bernsdorf A Giessmann T Modess C 2006Br J Clin Pharmacol2006,61,4:1
10Oral bioavailability of digoxin is enhanced by talinolol: evidence for involvement of intestinal P-glycoprotein 显示文摘Westphal K Weinbrenner A Giessmann T 2000Clin Pharmacol Ther2000,68,1:1
11Oral bioavailability ofdigoxin is enhanced by talinolol: evidence for involvement of intestinal P-glycoprotein 显示文摘Westphal K Weinbrenner A Giessmann T 2000Clin Pharmacol Ther2000,68,1:1
12The talinolol double-peak phenomenon is likely caused by presyst- emic processing after uptake from gut lumen显示文摘WEITSCHIES W BERNSDORF A GIESSMANN T et (d 2005Pharm Res2005,22,5:1
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费